A 2026 biopharmaceutical review in a journal I do not trust said there is no identified high-affinity receptor, no validated molecular target, and a wide disconnect between the tidy preclinical effects and any coherent pharmacology
With the addition of 0.5 mM GSH (P1), 88 vitrified oocytes resulted in 56 oocytes surviving (63.96.7)%, 8 with zona pellucida fractures (8.02.0)%, 16 with cytoplasmic shrinkage (16.54.0)%, and 11 with cytoplasmic lysis (11.74.7)%
Animal studies have reported faster recovery markers in connective tissue (tendon and ligament), muscle, and gastrointestinal tissue
Compound Reference Data Compound: GHK-Cu CAS Number: 89030-95-5 (GHK-Cu complex)
What is missing: in-person evaluation, comprehensive lab work, hands-on injection training
Regardless of route, product sourcing and purity remain the dominant modifiable risk factor